News

As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms ...
AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?
Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of ...
Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...
The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to ...
The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...
The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and longtime Stanford University professor, as the director of the Center for Drug ...
Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...
Lupin Pharmaceuticals’ Clomipramine Hydrochloride capsules are used “for the treatment of obsessions and compulsions in ...